Stocklytics Platform
Asset logo for symbol NVNO
enVVeno Medical Corporation
NVNO44
$3.07arrow_drop_up1.98%$0.06
Penny Stock
Asset logo for symbol NVNO
NVNO44

$3.07

arrow_drop_up1.98%
Key Stats
Open$3.03
Prev. Close$3.02
EPS-1.29
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$53.83M
PE Ratio-
LOWHIGH
Day Range3.03
3.23
52 Week Range2.44
6.97
Ratios
Revenue-
EBITDA Margin %-
EPS-1.29
Fundamentals
Gross Profit-
Payout Ratio-
Industry average yield2.90%
Last Dividend pay dateNov 30, 2020
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

NVNO-
US Healthcare Sector-
US Market-
warning

NVNO / Market

NVNO lose to the US Market which returned 273.38% over the last twenty four hours.
warning

NVNO / Healthcare Sector

NVNO lose to the US Healthcare sector which returned 2.80% over the last twenty four hours.

enVVeno Medical Corporation (NVNO) Statistics

enVVeno Medical Corporation (NVNO) is a publicly traded company that specializes in the development and manufacturing of medical instruments and devices. The company's stock statistics provide valuable insights into its performance in the market. Investors and analysts are able to assess the company's financial health, profitability, and growth potential by analyzing its valuation metrics, fundamentals, and stock performance compared to its sector.
When it comes to valuation metrics, enVVeno Medical Corporation's NVNO stock is evaluated based on various factors. These include its price-to-earnings ratio, price-to-sales ratio, and price-to-book ratio. These metrics give investors an idea of how the stock is priced relative to the company's earnings, sales, and book value. By analyzing these metrics, investors can determine if the stock is overvalued or undervalued.
add enVVeno Medical Corporation to watchlist

Keep an eye on enVVeno Medical Corporation

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How much debt does enVVeno Medical Corporation (NVNO) have?

enVVeno Medical Corporation (NVNO) has a total debt of $1.15M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$16.77M.
help

How has enVVeno Medical Corporation (NVNO) stock's performance compared to its sector and the market over the past year?

Over the past year, enVVeno Medical Corporation (NVNO) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 22.26%, enVVeno Medical Corporation has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 43.70%, it has fallen short of the market average. This comparison highlights enVVeno Medical Corporation's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of enVVeno Medical Corporation (NVNO) stock?

The PE ratio for enVVeno Medical Corporation (NVNO) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of enVVeno Medical Corporation (NVNO) stock?

The Earnings Per Share (EPS) for enVVeno Medical Corporation (NVNO), calculated on a diluted basis, is -$1.29. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of enVVeno Medical Corporation (NVNO) stock?

The operating margin for enVVeno Medical Corporation (NVNO) is 0%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of enVVeno Medical Corporation (NVNO) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of enVVeno Medical Corporation (NVNO) is -$23.2M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.

Take Your Investments to a Whole New Level